Table 5 Analysis of matched factors and outcomes between study and control groups.

From: Heart transplantation: comparing the impact of modified heart preservation with conventional methods

Variable

Variable level

Study (%)

Control (%)

Statistic (χ²)

P-value

Survival status

Alive

73 (75.26)

75 (77.32)

0.114

0.736

Deceased

24 (24.74)

22 (22.68)

  

Gender

Male

77 (79.38)

80 (82.47)

0.301

0.584

Female

20 (20.62)

17 (17.53)

  

Disease type

CAD

14 (14.43)

14 (14.43)

–

0.974

CM

75 (77.32)

77 (79.38)

  

Others

5 (5.15)

4 (4.12)

  

VHD

3 (3.09)

2 (2.06)

  

Gender

Male

84 (86.60)

78 (80.41)

1.347

0.246

Female

13 (13.40)

19 (19.59)

  

Combined transplant organ

No

97 (100.0)

96 (98.97)

–

1

Yes

0 (0.00)

1 (1.03)

  

Donor cause of death

Head injury

47 (50.00)

55 (56.70)

3.166

0.205

Cerebrovascular disease

37 (39.36)

38 (39.18)

  

Other

10 (10.64)

4 (4.12)

  

Recipient age

60 ≤ Age

20 (20.62)

22 (22.68)

0.786

0.853

50 ≤ Age < 60

33 (34.02)

34 (35.05)

  

18 ≤ Age < 50

39 (40.21)

34 (35.05)

  

Age < 18

5 (5.15)

7 (7.22)

  

Donor age

45 ≤ Age

29 (29.90)

19 (19.59)

6.087

0.048

25 ≤ Age < 45

47 (48.45)

64 (65.98)

  

Age < 25

21 (21.65)

14 (14.43)

  

Recipient BMI

BMI < 20

29 (29.90)

21 (21.65)

6.525

0.089

20 ≤ BMI < 23

28 (28.87)

22 (22.68)

  

23 ≤ BMI < 25

19 (19.59)

17 (17.53)

  

25 ≤ BMI

21 (21.65)

37 (38.14)

  

Donor BMI

BMI < 20

13 (13.68)

12 (12.37)

24.1

0

20 ≤ BMI < 23

54 (56.84)

28 (28.87)

  

23 ≤ BMI < 25

22 (23.16)

28 (28.87)

  

25 ≤ BMI

6 (6.32)

29 (29.90)

  

Preoperative cardiac ultrasound EF (M-mode)

< 20

16 (16.49)

9 (9.28)

9.688

0.021

20–25

24 (24.74)

44 (45.36)

  

25–30

27 (27.84)

19 (19.59)

  

30≤

30 (30.93)

25 (25.77)

  

History of cardiac surgery

No

86 (88.66)

87 (89.69)

0.053

0.817

Yes

11 (11.34)

10 (10.31)

  

History of diabetes

No

95 (97.94)

94 (96.91)

–

1

Yes

2 (2.06)

3 (3.09)

  

Chronic kidney disease

No

96 (98.97)

96 (98.97)

–

1

Yes

1 (1.03)

1 (1.03)

  

Preoperative blood purification or dialysis

No

97 (100.0)

94 (96.91)

–

0.246

Yes

0 (0.00)

3 (3.09)

  

Preoperative LVAD

No

97 (100.0)

96 (98.97)

–

1

Yes

0 (0.00)

1 (1.03)

  

IABP

No

96 (98.97)

87 (89.69)

7.806

0.005

Yes

1 (1.03)

10 (10.31)

  

ECMO

No

97 (100.0)

86 (88.66)

11.661

0.001

Yes

0 (0.00)

11 (11.34)

  

Mechanical ventilation

No

95 (97.94)

85 (87.63)

7.698

0.006

Yes

2 (2.06)

12 (12.37)

  

Respiratory system complications

No

50 (51.55)

90 (92.78)

41.058

0

Yes

47 (48.45)

7 (7.22)

  

Neurological complications

No

91 (94.79)

92 (94.85)

–

1

Yes

5 (5.21)

5 (5.15)

  

Renal complications

No

90 (93.75)

89 (91.75)

0.286

0.593

Yes

6 (6.25)

8 (8.25)

  

Diabetes mellitus

No

88 (93.62)

97 (100.0)

–

0.013

Yes

6 (6.38)

0 (0.00)

  

Positive sputum culture

No

50 (52.63)

85 (87.63)

28.162

0

Yes

45 (47.37)

12 (12.37)

  

Positive blood culture

No

88 (93.62)

92 (94.85)

0.133

0.716

Yes

6 (6.38)

5 (5.15)

  

Septic shock

No

89 (97.80)

95 (97.94)

–

1

Yes

2 (2.20)

2 (2.06)

  

Acute rejection reaction

No

96 (98.97)

97 (100.0)

–

1

Yes

1 (1.03)

0 (0.00)

  
  1. CAD Coronary artery disease, VHD, Valvular heart disease, CM Cardiomyopathy, LVAD Left ventricular assist device, IABP Intra-aortic balloon pump, ECMO Extracorporeal membrane oxygenation.